Small molecules that directly inhibit PLD1 or PLD2 represent novel approaches for the investigation of potential treatment of metastatic cancer and inflammatory diseases (Lavieri et al., 2009, 2010; Lewis et al., 2009; Scott et al., 2009). The gene discussed is PLD2; the disease is metastatic malignant neoplasm.